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An estimated 35–80% of inner-city children
are exposed to environmental tobacco smoke
(ETS) (DiFranza et al. 2004; Gergen et al.
1998; Hopper and Craig 2000; Kum-Nji
et al. 2006; Weaver et al. 1996). The health
effects associated with early-life ETS exposure
include reduced fetal growth, neurodevelop-
mental problems, respiratory disease including
asthma, increased cancer risk, and cardiovas-
cular disease, with some adverse effects mani-
festing in childhood and others in adulthood
(Samet 2005; U.S. Department of Health and
Human Services 2006). 
In earlier work, we documented an associ-
ation between ETS and developmental delay
(Rauh et al. 2004). Here we present estimates
of the cost of Early Intervention Services to
remediate these developmental delays attrib-
utable to ETS in the New York City Medicaid
population and in the total New York City
population. In the first step, based on the
CCCEH results (Rauh et al. 2004), we calcu-
lated the fraction of total delay attributable to
mothers’ ETS exposure during pregnancy
(the environmentally attributable fraction, or
EAF). The EAF was then multiplied by the
prevalence of delay, the size of the exposed
population, and the cost per intervention to
give the estimated annual cost of Early
Intervention Services among children with
ETS-related developmental delay. We find
that there are substantial costs for the inter-
ventions needed to address ETS-related devel-
opmental delay. These costs provide more
impetus to efforts on ETS prevention.
Finally, we describe feasible approaches to
intervention.
Health Effects of ETS Exposure
With respect to developmental effects, there is
no evidence of a threshold below which ETS
exposure is safe (DiFranza et al. 2004; Samet
2005). For example, Martin and Bracken
(1986) reported a doubling in the risk for low-
birth-weight babies when the nonsmoking
mother was exposed to ETS for ≥ 2 hr/day.
Based on meta-analysis, Windham et al.
(1999) estimated that passive maternal smok-
ing during pregnancy results in an average
decrease of 31 g in birth weight. The Ottawa
Prenatal Prospective Study reported that the
long-term effects of maternal passive smoking
during pregnancy were smaller in magnitude
but qualitatively similar to those of active
maternal smoking and included effects on
speech and language skills, intelligence,
visual/spatial abilities and mother’s rating of
behavior (Makin et al. 1991). Other studies
have also found an inverse relationship
between prenatal ETS exposure and indicators
of developmental delay, such as on the Bayley
Mental Development Index (MDI) and the
Wechsler Intelligence Scale for Children
(Rauh et al. 2004; Yolton et al. 2005).
With respect to nondevelopmental effects,
ETS exposure in childhood has long been
established as a “trigger” for asthma in chil-
dren (Gergen et al. 1998; Mannino et al.
2002). Nationally, a 1992 report by the U.S.
Environmental Protection Agency (EPA)
attributed 200,000 of 1,000,000 cases of
childhood asthma exacerbation to secondhand
smoke (U.S. EPA 1992). Based on nationally
representative data from 1988–1994, Gergen
et al. (1998) estimated that between 40 and
60% of the cases of asthma among children
2 months to 5 years of age who were exposed
to ETS are attributable to ETS exposure.
Some studies have found an association
between early-life ETS exposure and child-
hood and adult cancer, although results have
been inconsistent (Bofetta 2000; Janerich
et al. 1990; Ji et al. 1997; Sasco and Vainio
1999; Sorahan et al. 1997; Stockwell et al.
1992; Vineis et al. 2005). 
In addition to the main effects of ETS on
early development, there is some evidence of
synergistic interactions between ETS and air
pollutants and between ETS and psychosocial
stress, such that the co-occurrence of ETS with
either of the two other exposures multiplies the
risk of adverse effects. In the CCCEH prospec-
tive cohort in New York City, such an interac-
tion effect of ETS and polycyclic aromatic
hydrocarbons (PAH)–DNA adducts was
observed on birth weight and head circumfer-
ence (Perera et al. 2004). In addition, the
impact of ETS on 2-year cognitive development
was exacerbated by material hardship (Rauh
et al. 2004). In the same cohort study, evidence
showed an interaction between exposure to
prenatal PAHs and postnatal ETS on increased
risk of respiratory problems in children (Miller
et al. 2004). Such observed interactions suggest
that health-related costs associated with expo-
sure to secondhand smoke may be increased
when other “toxic” exposures co-occur.
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BACKGROUND AND OBJECTIVES: Early-life exposure to environmental tobacco smoke (ETS) can
result in developmental delay as well as childhood asthma and increased risk of cancer. The high
cost of childhood asthma related to ETS exposure has been widely recognized; however, the eco-
nomic impact of ETS-related developmental delay has been less well understood. 
METHODS AND RESULTS: The Columbia Center for Children’s Environmental Health (CCCEH)
has reported adverse effects of prenatal ETS exposure on child development in a cohort of minority
women and children in New York City (odds ratio of developmental delay = 2.36; 95% conﬁdence
interval 1.22–4.58). Using the environmentally attributable fraction (EAF) approach, we estimated
the annual cost of one aspect of ETS-related developmental delay: Early Intervention Services. The
estimated cost of these services per year due to ETS exposure is > $50 million per year for New
York City Medicaid births and $99 million per year for all New York City births. 
CONCLUSION: The high annual cost of just one aspect of developmental delay due to prenatal expo-
sure to ETS provides further impetus for increased prevention efforts such as educational programs to
promote smoke-free homes, additional cigarette taxes, and subsidizing of smoking cessation programs. 
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11 July 2006]The fetus and young child are particularly
susceptible to the effects of ETS and its chemi-
cal constituents, including PAHs (Perera et al.
2004). For example, several studies of paired
cord and maternal blood taken at delivery have
shown higher levels of PAH–DNA adducts per
estimated unit of exposure (Perera et al. 2004;
Whyatt et al. 2001). Signiﬁcantly higher coti-
nine levels have also been observed in cord
blood compared to maternal samples, probably
as a consequence of a slower rate of clearance
of this nicotine metabolite from the fetal sys-
tem (Perera et al. 2004; Whyatt et al. 2001).
ETS-Related 
Developmental Delay and
Some Estimated Costs
The CCCEH Cohort Study: ETS-related
developmental delay. The cohort study includes
African-American and Latina mothers enrolled
during pregnancy and their children. Women
who reported active smoking during pregnancy
were excluded, as were women who reported
diabetes, hypertension, positive HIV status, or
drug or alcohol abuse, or whose previous babies
were low birth weight.
The analysis of the risk of ETS for adverse
child development involved 226 infants from
the CCCEH cohort who had reached 24
months of age at the time of the analysis and
had complete data on all measures (Rauh et al.
2004). ETS exposure was self-reported and
cotinine-verified. Prenatal ETS exposure
occurred in 40.2% of the children. Child
development was measured using the Mental
Development Index (MDI) of the Bayley
Scales of Infant Intelligence. The MDI is a use-
ful measure of mental/cognitive performance
when administered after 18 months of age
(Slater 1995). Several studies conﬁrm the abil-
ity of the MDI to identify children who will
demonstrate developmental delay on tests of
school-age ability and achievement measures
(e.g., Siegel 1979; Singer and Fagan 1984). 
Because estimation of the effects of ETS
exposure on neurodevelopment can be compli-
cated by confounding, inaccurate assessment of
exposure, colinearity of postnatal ETS expo-
sure, and other prenatal maternal exposures
(Eskenazi and Castorina 1999), the regression
models adjusted for the effects of race/ethnicity,
sex, gestational age (weeks), age at test adminis-
tration, maternal education, marital status,
material hardship, and postnatal ETS exposure.
Self-reported prenatal ETS exposure was vali-
dated with a biomarker (cotinine levels in cord
blood). The models tested the effects of ETS
among women with and without material hard-
ships. There was a signiﬁcant negative impact
of ETS (p = 0.005), resulting in an estimated
mean (± SE) 4.8 ± 1.6 point average deﬁcit in
MDI at 24 months of age and an odds ratio of
2.36 for developmental delay [95% conﬁdence
interval (CI), 1.22–4.58]. A separate model
indicated a signiﬁcant interaction between ETS
and material hardship (p = 0.03), such that chil-
dren who were exposed to both ETS and mate-
rial hardship had an even greater average
cognitive deﬁcit of 7.1 ± 3.3 points (Rauh et al.
2004). It is likely that the effects of ETS on
development were underestimated because
women who actively smoked or used illicit
drugs were ineligible for enrollment, and the
study design eliminated most preterm deliveries
(Rauh et al. 2004). 
With a Bayley MDI score < 80 to catego-
rize developmental delay, the CCCEH cohort
has a high rate of developmental delay (32.3%
of the children in the cohort). However, this
rate is comparable to that found in other pre-
dominantly low-income New York samples.
For example, in a sample of 12- to 36-month-
old low-income children attending a pediatric
ambulatory clinic in New York, Dreyer et al.
(1996) reported that 49% had Bayley MDI
scores of ≤ 85, and 9% had scores < 70. In a
recent study of Hispanic and African-
American 2-year-olds in the South Bronx,
30% had Bayley MDI scores < 70 (Huberman
et al. 2003), whereas 17.9% of the children in
the CCCEH cohort scored < 70 on the
Bayley MDI.
Unlike most prior studies, the CCCEH
cohort study clearly differentiated the effects of
prenatal and postnatal ETS exposure. The
results were consistent with a prior study of the
cognitive effects of ETS exposure that reported
that children of mothers exposed to ETS dur-
ing pregnancy scored below the unexposed
group on the Peabody Picture Vocabulary Test,
Perceptual Organization, and Freedom from
Distractibility, and on measures of language,
intelligence, and attention (Makin et al. 1991). 
Calculation of cost-related Early
Intervention Services. To calculate the costs
of developmental deﬁcits attributable to pre-
natal ETS exposure, we employed the general
model (Trasande et al. 2005):
Costs attributable to ETS exposure = 
disease rate (background rate of 
developmental delay) × EAF × exposed 
population size × cost per case [1]
The disease rate (25.9%) was based on
data from the CCCEH study described above
(Rauh et al. 2004). The EAF method was
developed by the Institute of Medicine
(Institute of Medicine 1981), and has been
widely used to calculate the environmentally
attributable costs of pediatric cancer, asthma,
lead poisoning, neurodevelopmental disabili-
ties, and methylmercury poisoning (Landrigan
et al. 2002). 
The EAF is a composite value and is the
product of the prevalence of ETS exposure
(fraction of population exposed) and the rela-
tive risk of delay associated with exposure. In
the CCCEH study, the observed odds ratio for
developmental delay was 2.36 (95% CI,
1.22–4.58). Because the odds ratio overesti-
mates the estimated relative risk when the out-
come is common (Rothman 1996), based on
data from Rauh et al. (2004), the relative risk of
1.61 (95% CI, 1.11–2.34) was used to calculate
the EAF. The “exposed population size” is the
population at risk (i.e., exposed to ETS) and
was estimated in two ways: a) based on the
number of New York City children with char-
acteristics similar to those in the CCCEH
cohort (i.e., Medicaid births in New York City
in 2002); and b) based on the total number of
New York City births in 2002 (New York City
Department of Health and Mental Hygiene
2002). Our ﬁrst analysis used Medicaid births
in New York City as a comparable population
because > 90% of the births in the CCCEH
were to mothers on Medicaid. The prevalence
of exposure in both populations was estimated
to be 40.2% based on the CCCEH data and
other studies (Gergen et al. 1998; Pirkle et al.
1996; Rauh et al. 2004). A prevalence of expo-
sure of about 40% is likely to be an underesti-
mate for the Medicaid births because the
CCCEH cohort, by design, includes nonsmok-
ers, and inner-city exposure rates have been
shown to be as high as 70–80% (DiFranza
et al. 2004; Gergen et al. 1998; Pirkle et al.
1996; Weaver et al. 1996). Our second analysis
extrapolated to all New York City births to cal-
culate an upper estimate for the costs of Early
Intervention Services. The rationale was that,
according to the literature, the adverse develop-
mental effects of prenatal ETS exposure are
seen in diverse populations and are not limited
to Medicaid births (Makin et al. 1991; Rauh
et al. 2004; Yolton et al. 2005). 
The “cost per case” is the average cost per
child for Early Intervention Services over the
average time of enrollment (provided by the
New York City Department of Health and
Mental Hygiene, Early Intervention Program,
personal communication). U.S. law mandates
that Early Intervention Services be provided to
those children at risk of developmental delay
(Kirby et al. 1993). The Early Intervention
Program consists of home-based services pro-
vided to the family who elects to participate,
with a typical child receiving about four con-
tacts per week. Developmentally delayed chil-
dren are defined as having an MDI < 80 at
24 months of age and are referred to the Early
Intervention Program for screening and ser-
vices. Among all New York City children who
were referred to Early Intervention, an average
of 70% were evaluated, found to be eligible,
and participated in the service program
between July 2003 and June 2004 (New York
City Department of Health and Mental
Hygiene, Early Intervention Program, personal
communication). Citywide, the total cost for
Early Intervention Services amounted to
Miller et al.
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participating during the 1-year period between
July 2003 and June 2004 for annual cost per
case of approximately $11,500 (New York
City Department of Health and Mental
Hygiene, Early Intervention Program, personal
communication). Each child is enrolled for an
average of 18 months, which costs approxi-
mately $17,200. We take this as our “cost per
case” (Table 1 summarizes the data used in the
health cost calculation). 
Table 2 summarizes the estimated annual
costs of ETS-related Early Intervention for
New York City Medicaid births and for all
New York City births in 2002. These costs
($51.5 million and $99 million, respectively),
would accrue each year as “new” children who
were exposed in utero to ETS become eligible
for enrollment. So, for example, over a 10-year
period the present value of the costs for Early
Intervention Services attributable to prenatal
ETS exposure among New York City
Medicaid births would be approximately $439
million (based on a 3% annual discount rate).
Although the estimated costs of Early
Intervention are signiﬁcant, they represent only
a fraction of all the costs of developmental
delay due to ETS exposure. Early Intervention
programs do not capture all those children
who are delayed, leaving a substantial propor-
tion of cases undetected and unaddressed by
health providers and early childhood programs
(Shonkoff and Mesiels 2000). Nor do Early
Intervention programs ameliorate all the effects
of developmental delay for those enrolled. 
Costs from residual developmental prob-
lems not corrected by Early Intervention could
include those of some Special Education ser-
vices. In 1999–2000, the average cost for each
student in special education was $12,500 ver-
sus $6,500 for a non-special-education student
(National Association of State Boards of
Educations 2002). In addition, grade retention
costs about $6,000 per year per student
(Shepard and Smith 1990). In a cost–beneﬁt
analysis of the Perry Preschool Project, for
every dollar invested in early intervention, sav-
ings of approximately $7 are accrued as a result
of decreased rates of special education and
grade retention among the intervention group
(Barnett 1985). Grade retention, in turn, is
predictive of the likelihood of graduating from
high school, which serves as an important pre-
dictor of socioeconomic well-being and health
status (Anderson et al. 2003). Thus, the pre-
vention of ETS exposure can be viewed as an
investment good that yields personal and social
beneﬁts into the future.
Discussion
This analysis highlights the substantial burden
of developmental impairment and illness asso-
ciated with prenatal and postnatal ETS expo-
sure. We estimate that the annual cost of Early
Intervention Services for developmental delay
attributable to ETS exposure in New York
City is slightly over $51 million for New York
City Medicaid births and $99 million for all
New York City births. 
The costs estimated here represent just one
element of the costs of developmental delay
associated with ETS. The economic costs of
postnatal ETS also include costs of develop-
mental delay that cannot be remediated
through early intervention 
This analysis adds to the other evidence of
substantial costs associated with other health
effects of ETS. In particular, postnatal ETS
exposure is a well-known trigger for childhood
asthma (Gergen et al. 1998; Mannino et al.
2002); and the high cost of childhood asthma
has been widely recognized (American Legacy
Foundation 2004; Sullivan et al. 2005; Wang
et al. 2005) For example, among children
2 months to 5 years of age, an estimated
133,800–161,600 excess cases of asthma in the
U.S. are attributed to ETS exposure (Gergen
et al. 1998). The estimated cost of pediatric
asthma care per case ranges from $385/year for
usual care (Sullivan et al. 2005) to $791 includ-
ing parent’s loss of productivity due to chil-
dren’s asthma-related school absence days
(Wang et al. 2005). Some evidence also suggests
a causal role of ETS in cancer in childhood or
adulthood (Bofetta 2000; Janerich et al. 1990;
Sorahan et al. 1997; Stockwell et al. 1992;
Vineis et al. 2005). The established link
between postnatal ETS and asthma and the
potential link between ETS and cancer suggest
that in the New York City population there are
likely to be substantial economic costs associated
with these consequences of ETS as well. Thus,
the costs described above likely represent only a
fraction of the true costs of ETS-related effects.
The limitations of this analysis should be
noted. First, because the CCCEH cohort is
comprised of nonsmoking, healthy women, the
relative risk and EAF based on cohort data may
underestimate the risk to the Medicaid popula-
tion. Second, in extrapolating the costs of Early
Intervention to the New York City population
we were unable to conduct a finer analysis,
because we did not have data on the effects on
development according to median household
income or other variables such as maternal edu-
cation. Third, these analyses are based on
observational data and thus are subject to con-
founding by unobservable risk factors. 
The data support stronger efforts to pre-
vent ETS exposure to pregnant women and
children. Many cities and states have passed
smoke-free legislation, including New York
City; Albuquerque, New Mexico; Maine; and
Connecticut. Federal, state, and local legisla-
tion has been effective in reducing second-
hand smoke exposure in the workplace and
public places. In fact, nonsmokers’ exposure
to tobacco smoke has fallen by > 70% from
1988–1991 to 1999–2000 (National Cancer
Institute 2005; Pirkle et al. 2006). However,
there is still a very high prevalence of ETS
exposure among U.S. children, ranging from
35 to 80% depending on the method of
measurement used and the population stud-
ied (Kum-Nji et al. 2006); and risks from
smoking in the home remain. 
Several approaches have been effective in
reducing ETS exposure in the home (Emmons
et al. 2001; Hovell et al. 2000; Okah et al.
2002). The first approach is counseling by
health professionals and the promotion of
home smoking restrictions: a “rule of the
house” that forbids smoking inside the home.
Only 12.5–25% of homes with smokers
restrict smoking; and families of lower socio-
economic status are even less likely to have
home restrictions (Norman et al. 1999).
Reason for this low rate could be insufﬁcient
information on the risks of ETS to infants and
children and the lack of professional counsel-
ing. For example, when mothers were coun-
seled by health professionals about the dangers
of passive smoke exposure, there was a dra-
matic reduction in children’s exposure to ciga-
rettes per week—by almost 90% over 12
months (Hovell et al. 2000). Similarly, a study
targeting low-income families with young
Economic impact of early life ETS exposure
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Table 1. Data for the health cost calculation.
Value
Delay rate (%)a 25.9
Prevalence of exposure (%)a 40.2
EAFa 0.647
Exposed population size, New York City (2002) (n)
Medicaid births, exposedb 25,500
All births, exposed 49,400
Cost per casec $17,200 
aRauh et al. 2004. bNumber of births from New York City
Department of Health and Mental Hygiene (2002). cNew
York City Department of Health and Mental Hygiene, Early
Intervention Program (personal communication).
Table 2. Estimated annual costs of ETS-related developmental delay, 2004: Early Intervention Services for
New York City Medicaid births and all New York City births. 
New York City Medicaid birthsa All New York City birthsa
No. of live births 63,462 122,937
No. exposed 25,500 49,400
No. delayed due to ETS 4,300 8,300
Remedial intervention Early Intervention Early Intervention
No. enrolled in Early Intervention 3,000 5,800
Total cost $51.5 million  $99 million
aBased on data from New York City Department of Health and Mental Hygiene (2002).children found that parents reduced their
child’s ETS exposure after training and follow-
up counseling (Emmons et al. 2001).
However, barriers to the adoption of home
smoking restriction, such as male dominance
in the family, must be addressed. 
A second approach to changing smoking
behavior and reducing children’s exposure to
ETS is through market interventions, including
an increased tax on cigarettes to cover the exter-
nal health costs generated by ETS exposure. 
Another potential intervention is govern-
ment subsidizing of smoking cessation pro-
grams. Such programs could be targeted to
smokers in households with or expecting chil-
dren. Smoking cessation programs range from
brief advice and counseling, to nicotine replace-
ment therapy (e.g., nicotine patches), to inten-
sive clinical interventions including bupropion
therapy (Parrott and Godfrey 2004). A major
appeal of government subsidizing of smoking
cessation is the cost-effectiveness of cessation
programs (Parrott and Godfrey 2004). The
Agency for Health Care Policy and Research
(2005) estimated that the average cost per
smoker undergoing a smoking cessation inter-
vention is $165.61. This can be compared to
the substantial health costs to the smoker as
well as the smokers’ families. If such programs
were targeted to New York City families,
the total costs of smoking cessation would be
only 8.7% of the potential costs of Early
Intervention Services for children developmen-
tally delayed due to their mothers’ passive
maternal smoke exposure during pregnancy. 
Conclusion
The present analysis shows that the economic
costs of developmental delay due to prenatal
ETS exposure are substantial. Adding to a
large body of evidence on the health, social,
and economic costs of ETS, these data provide
additional impetus for interventions to protect
this vulnerable population.
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